Product NDC: | 0085-1341 |
Proprietary Name: | ASMANEX |
Non Proprietary Name: | Mometasone Furoate |
Active Ingredient(s): | 220 ug/1 & nbsp; Mometasone Furoate |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | INHALANT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1341 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021067 |
Marketing Category: | NDA |
Start Marketing Date: | 20050330 |
Package NDC: | 0085-1341-02 |
Package Description: | 1 POUCH in 1 CARTON (0085-1341-02) > 1 INHALER in 1 POUCH > 60 INHALANT in 1 INHALER |
NDC Code | 0085-1341-02 |
Proprietary Name | ASMANEX |
Package Description | 1 POUCH in 1 CARTON (0085-1341-02) > 1 INHALER in 1 POUCH > 60 INHALANT in 1 INHALER |
Product NDC | 0085-1341 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mometasone Furoate |
Dosage Form Name | INHALANT |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20050330 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | MOMETASONE FUROATE |
Strength Number | 220 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |